化学
对接(动物)
效力
立体化学
结构-活动关系
布氏锥虫
毒性
体外
铅化合物
EC50型
药理学
组合化学
生物化学
有机化学
基因
护理部
医学
作者
Chiara Borsari,Rosaria Luciani,Cecilia Pozzi,Ina Poehner,Stefan Henrich,Matteo Trande,Anabela Cordeiro‐da‐Silva,Nuno Santarém,Catarina Baptista,Annalisa Tait,F. Di Pisa,Lucia Dello Iacono,Giacomo Landi,Sheraz Gul,Markus Wolf,Maria Kuzikov,Bernhard Ellinger,Jeanette Reinshagen,Gesa Witt,Philip M. Gribbon
标识
DOI:10.1021/acs.jmedchem.6b00698
摘要
Flavonoids represent a potential source of new antitrypanosomatidic leads. Starting from a library of natural products, we combined target-based screening on pteridine reductase 1 with phenotypic screening on Trypanosoma brucei for hit identification. Flavonols were identified as hits, and a library of 16 derivatives was synthesized. Twelve compounds showed EC50 values against T. brucei below 10 μM. Four X-ray crystal structures and docking studies explained the observed structure-activity relationships. Compound 2 (3,6-dihydroxy-2-(3-hydroxyphenyl)-4H-chromen-4-one) was selected for pharmacokinetic studies. Encapsulation of compound 2 in PLGA nanoparticles or cyclodextrins resulted in lower in vitro toxicity when compared to the free compound. Combination studies with methotrexate revealed that compound 13 (3-hydroxy-6-methoxy-2-(4-methoxyphenyl)-4H-chromen-4-one) has the highest synergistic effect at concentration of 1.3 μM, 11.7-fold dose reduction index and no toxicity toward host cells. Our results provide the basis for further chemical modifications aimed at identifying novel antitrypanosomatidic agents showing higher potency toward PTR1 and increased metabolic stability.
科研通智能强力驱动
Strongly Powered by AbleSci AI